About Valitor

Valitor, Inc. has developed novel methods of modifying therapeutic proteins to achieve substantial control over their pharmacokinetics, target specificity and bioactivity. Their technology platform can be broadly applied to improve the pharmacological properties of many protein drugs that are currently approved or under development. They currently have three development pipelines in the fields of dermatology, ophthalmology, and orthopedics that highlight the capabilities of their novel drug prod

Top 100 in Developer Tools in United States
Company Highlights
Year Founded

2010

icon-altEmployees

17

Location (HQ)

USA

Since Last Funding

1 year 11 months

Monthly Website Visitors

1.9K

icon-altTotal Investment Amt

$39M

Last Funding Round

Series B

icon-altYoY Headcount Growth

-14.93%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Similar Companies

Biotechnology

Biotechnology Research

Medical

Therapeutics